Micar21 Overview

  • Founded
  • 2016

  • Status
  • Private

  • Employees
  • 9

  • Latest Deal Type
  • Angel

  • Investors
  • 1

Micar21 General Information


Provider of personalized genetics screen analysis intended to improve quality of life. The company offers in-silico drug design screening for biologically active compounds for customized treatments and data-driven insights tailored to the individual, enabling patients to get drugs for rare diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
  • 38A, Karamfil street
  • Sofia, 1616
  • Bulgaria

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Micar21 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) Completed Startup
To view Micar21’s complete valuation and funding history, request access »

Micar21 Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Provider of personalized genetics screen analysis intended to improve quality of life. The company offers in-silico drug
Other Pharmaceuticals and Biotechnology
Sofia, Bulgaria
9 As of 2021


n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
0000 000000000
San Francisco, CA
000 As of 0000
0000000000 00000


ommodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fu
0000 000000000
Hong Kong, Hong Kong
00 As of 0000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Micar21 Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Atomwise Venture Capital-Backed San Francisco, CA 000 00000 0000000000 00000
00000000 00000000 Venture Capital-Backed Hong Kong, Hong Kong 00 00000 00000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Micar21 Executive Team (5)

Name Title Board Seat Contact Info
Dimitar Dimitrov Co-Founder & Chief Executive Officer
Elina Mihaylova Chief Operating Officer
Filip Fratev Co-Founder, Chairman & Chief Scientific Officer
Mill Greenberg Chief Business Development Officer
Kristina Eskenazi Chief Communications Officer
To view Micar21’s complete executive team members history, request access »

Micar21 Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Micar21 Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Apolo Exclusive Other Minority 000 0000 000000 0
To view Micar21’s complete investors history, request access »